期刊文献+

白藜芦醇抑制结肠癌干细胞增殖并增强MICA/B的表达 被引量:12

Resveratrol inhibits cell proliferation and up-regulates MICA/B expression in human colon cancer stem cells
下载PDF
导出
摘要 目的研究白藜芦醇(Res)对结肠癌干细胞(CCSC)增殖、凋亡和免疫原性的影响。方法采用无血清培养法由HCT116结肠癌细胞诱导培养CCSC,通过检测CCSC标志物CD133、CD44进行鉴定。MTT法检测Res对CCSC增殖的影响;annexinⅤ-FITC/PI双染色结合流式细胞术检测Res对CCSC凋亡的影响;流式细胞术检测Res对CCSC生长周期及主要组织相容性复合体Ⅰ类分子相关链A/B(MICA/B)表达的影响。结果 HCT116细胞在无血清培养下成球生长。球形细胞中CD133+细胞占91.07%±1.79%,CD44+细胞占90.33%±1.78%。与对照组相比,Res能明显抑制CCSC增殖,并且呈时间、剂量依赖性;Res作用48 h后,CCSC细胞周期G0/G1期比例显著升高,S期下降,呈剂量依赖性;随着药物浓度增加,CCSC的凋亡率增加,MICA/B的表达增强。结论从HCT116结肠癌细胞成功诱导培养出CCSC,Res能剂量依赖性地抑制CCSC的增殖,与阻滞细胞于G0/G1期,并诱导细胞凋亡有关;Res能增强CCSC中MICA/B的表达,增强其免疫原性。 Objective To investigate the effect of resveratrol (Res) on the proliferation, apoptosis and immunogenicity of colorectal cancer stem cells (CCSCs). Methods The CCSCs were induced from colon cancer cell line HCT116 in serum-free medium (SFM). The expressions of CD133 and CD44 were detected by flow cytometry to identify CCSCs. After treatment with Res at (12.5 -200.0) pmol/L, the effect of Res on CCSC proliferation was detected by MTT assay; cell apoptosis was examined by flow cytometry corrbined with annexin V-FITC/PI staining; cell cycle and the expression of major histocompatibility comp4ex class I-related chain A and B (MICA/B) were assessed by flow cytometry. Results HCTll6 cells formed cancer stem cell spheres in SFM. The proportion of CD133^+ cells in cell spheres was (91.07 ± 1.79)%, and CD44^+ cells was (90.33 ± 1.78)%. Compared with control groups, Res significantly inhibited CCSC proliferation in a time- and dose-depended manner. After treatment with Res for 48 hours, the proportion of cells increased in the G0/G1 phase an.d decreased in the S phase, both in a dose-depended manner. Apoptosis rate of CCSCs and the expression of MICA/B were raised with the increasing concentration of Res. Conclusion CCSCs were successfully induced from HCT116 colon cancer cell line. Res could depress CCSC proliferation in a time-and dose-depended manner, arrest cell cycle in the GO/G1 phase and promote cell apoptosis. Res could up-regulate the expression of MICA/B in CCSCs and enhance cell immunogenicity.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2015年第7期889-893,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 江苏省六大人才高峰课题(WS-067)
关键词 白藜芦醇 结肠癌干细胞 凋亡 细胞周期 主要组织相容性复合体I类分子相关链A/B(MICA/B) resveratrol colon cancer stem cells apoptosis cell cycle major histocompatibility complex class I-relatedchain A and B (MICA/B)
  • 相关文献

参考文献24

  • 1Malik B, Nie D. Cancer stem cells and resistance to chemo and radio therapy [J]. Front Biosci (Elite Ed), 2012, 4:2142 -2149.
  • 2Gottschling S, Schnabel PA, Herth FJ, et al. Are we missing the target-Cancer stem cells and drug resistance in non-small cell lung cancer [J]. Cancer Genomics Proteomics, 2012, 8(9) : 275 -286.
  • 3Sampieri K, Fodde R. Cancer stem cells and metastasis [J]. Semin Cancer Biol, 2012, 17(22) : 187 -193.
  • 4Ciurea ME, Georgescu AM, Purcaru SO, et al. Cancer stem cells: biological functions and therapeutically targeting[ J]. Int J Mol Sci, 2014, 15(5): 8169-8185.
  • 5Nosrati A, Naghshvar F, Khanari S. Cancer stem cell markers CD44, CD133 in primary gastric adenocarcinoma[ J]. Int J Mol Cell Med, 2014, 3(4) : 279 -286.
  • 6Bhullar KS, Hubbard BP. Lifespan and heahhspan extension by resveratrol [J]. Biochim Biophys Acta, 2015, 1852(6) : 1209 -1218.
  • 7Summerlin N, Soo E, Thakur S, et al. Resveratrol nanoformulations: Challenges and opportunities [ J]. Int J Pharm, 2015, 479 ( 2 ) : 282 - 290.
  • 8姜玉婷,费素娟,陈复兴,刘军权,陈玲,李映,陶征中.白藜芦醇对γδT细胞杀伤结肠癌SW-1116细胞的影响及机制研究[J].中华微生物学和免疫学杂志,2011,31(8):697-701. 被引量:4
  • 9Baena R, Salinas P. Diet and colorectal cancer [ J ]. Maturitas,2015, 80(3) : 258 -264.
  • 10Chela S, Huang EH. The colon cancer stem eel/ holds keys to future cancer therapy [ J ]. J Gastrointest Surg, 2014, 18(5) : 1040 -1048.

二级参考文献63

  • 1Boocock DJ, Faust GE, Patel KR, et al. Phase Ⅰ dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a poten- tial cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prey, 2007, 16(6): 1246-1252.
  • 2Bouet-Toussaint F, Cabillic F, Toufirais O, et al. Vgamma9Vde- lta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. Cancer Immunol Immunother, 2008, 57(4) : 531-539.
  • 3Jameson JM, Cauvi G, Sharp LL, et al. Gammadeha T cell-in- duced hyaluronan production by epithelial cells regulates inflam- mation. J Exp Med, 2005, 201 (8) : 1269-1279.
  • 4Feng YH, Zhou WL, Wu QL, et al. Low dose of resveratrol en- hanced immune response of mice. Acta Pharmacol Sin, 2002, 23(10) : 893-897.
  • 5McKenzie MD, Dudek NL, Mariana L, et al. Perforin and Fas in- duced by IFNgamma and TNFalpha mediate beta cell death by OT- Ⅰ CTL. Int Immunol, 2006, 18(6) : 837-846.
  • 6Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8^+ T cells by a flow eytometric assay for degranulation. J Immunol Methods, 2003, 281 (1-2) : 65-78.
  • 7Hoshino R, Chatani Y, Yamori T, et al. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene, 1999, 18(3) : 813-822.
  • 8Black E J, Walker M, Clark W, et al. Cell transformation by v-Jun deactivates ERK MAP kinase signalling. Oncogene, 2002, 21 (42) : 6540-6548.
  • 9Tang D, Wu D, Hirao A, et al. ERK activation mediates cell cy- cle arrest and apoptosis after DNA damage independently of p53. J Biol Chem, 2002, 277(15): 12710-12717.
  • 10Chen D, Heath V, O'Garra A, et al. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells. J Immunol, 1999, 163(11):5796-5805.

共引文献7

同被引文献165

引证文献12

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部